This aligns with earlier studies that show that myo-inositol (MI) exhibits anti-inflammatory properties [27], reduces fasting plasma insulin and glucose concentrations in women with gestational diabetes [28], and improves insulin sensitivity and glucose tolerance in T2DM patients when co-supplemented with its isomer D-chiro-inositol [29]. This evidence concerns the gene INS and gestational diabetes.